KYRA ISAACS: Open Payments
NPI 1750990461 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 25 payments from 13 companies in 2025. Trend: 2023 $334 · 2024 $504 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $240 |
| Sumitomo Pharma America, Inc. | 5 | $114 |
| Ferring Pharmaceuticals Inc. | 3 | $63 |
| TOLMAR, INC. | 2 | $57 |
| 180 Medical, Inc. | 2 | $46 |
| Endo USA, Inc. | 2 | $43 |
| Valencia Technologies Corporation | 1 | $26 |
| ABC Home Medical Supply, Inc. | 1 | $26 |
| UROGEN PHARMA, INC. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: AMS 700, ORGOVYX, ADSTILADRIN, SpaceOAR VUE System - 10mL, ELIGARD, GEMTESA, AVEED, Rezum Generator.
Industry payments across DE — which companies pay providers there.
